These outcomes, along with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the notion of concentrating on ACKR3 as a novel strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-linked Ailments.(3) Other than once the affected individual